Intellia Therapeutics
NTLA
#4597
Rank
NZ$2.84 B
Marketcap
$28.01
Share price
4.56%
Change (1 day)
-33.90%
Change (1 year)

P/S ratio for Intellia Therapeutics (NTLA)

P/S ratio as of November 2024 (TTM): 37.1

According to Intellia Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.76. At the end of 2024 the company had a P/S ratio of 47.0.

P/S ratio history for Intellia Therapeutics from 2016 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202447.0-37.6%
202375.330.42%
202257.7-78.32%
2021266339.37%
202060.6254.65%
201917.1-15.77%
201820.3-34.9%
201731.28.8%
201628.6

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA